isn frontiers logo 01

THIN 1200x168 3 02

February 24

  

Saturday, February 24 Eminence Hall
Nishiki Room

9:10-10:30

Symposium: DKD & CVD: Basic

(Joint with the Japan Diabetes Society)

Chairs: Kumiko Torisu (Japan), Kriengsak Vareesangthip (Thailand)

 

Diabetic kidney disease: New targets for treatment

Speaker: Katherine Tuttle (USA)

 

New approaches to treatment of DKD

Speaker: Robyn Langham (Australia)

 

Inflammation in diabetic kidney disease

Speaker: Sydney Tang (Hong Kong)

 

Vaspin and proximal tubular cell injury in metabolic syndrome

Speaker: Atsuko Nakatsuka (Japan)

 

Symposium: aHUS and systemic vascular injury

(Co-sponsored by Alexion)

Chairs: Matsuhiko Hayashi (Japan), Yugo Shibagaki (Japan)

 

Transplantation and thrombotic microangiopathy (TMA)

Speaker: Toby Coates (Australia)

 

Update on STEC-HUS

Speaker: Christine B. Sethna (USA)

 

Atypical HUS in pediatric patients

Speaker: Toshihiro Sawai (Japan)

 

Atypical HUS in adult patients

Speaker: Yoko Yoshida (Japan)

 

10:45-12:05

Symposium: Dialysis and CVD: Clinical

(Co-sponsored by Kyowa Hakko Kirin Co., Ltd.)

Chairs: John Cunningham (UK), Tae Yamamoto (Japan)

 

Dialysis and CVD: Chinese cohort study

Speaker: Xueqing Yu (China)

 

Management of CKD-MBD in haemodialysis: Lessons from COSMOS

Speaker: Jorge B. Cannata-Andía (Spain)

 

CKD and CVD in Asia: Lessons from cohort studies and clinical trials

Speaker: Vivekanand Jha (India)

 

Clinical studies of cardiovascular interventions in PD patients

Speaker: David Johnson (Australia)

 

Symposium: CKD-MBD & CVD

(Co-sponsored by Ono Pharmaceutical Co., Ltd.)

Chairs: Orson Moe (USA), Daisuke Nagata (Japan)

 

Evidence for and against the link between MBD and CVD

Speaker: Ravi Thadhani (USA)

 

Calcimimetics and CVD

Speaker: Takayuki Hamano (Japan)

 

Vascular calcification

Speaker: Cecilia Giachelli (USA)

 

Hidden hypercalcemia

Speaker: Yoshitsugu Obi (Japan)

 

13:25-14:20

Plenary Lecture

Elucidation of human oxygen sensing pathways: implications for nephrology

Speaker: Peter Ratcliffe (UK)

Chairs: Kai-Uwe Eckardt (Germany), Kosaku Nitta (Japan)

14:20-14:55

Keynote

Cardiovascular trials and kidney disease

Speaker: Vlado Perkovic (Australia)

Chairs: Motoko Yanagita (Japan), Vivekanand Jha (India)

15:00-16:20

Symposium: Transplantation & CVD

(Joint with the Japanese Society for Dialysis Therapy)

Chairs: Yon Su Kim (Korea), Xueqing Yu (China)

 

Antibody mediated rejection

Speaker: Toby Coates (Australia)

 

Long term renal allograft survival

Speaker: Adrian Liew (Singapore)

 

Cardiovascular disease after kidney transplantation

Speaker: Philip Li (Hong Kong)

 

Marginal donor in living-donor kidney transplantation

Speaker: Tadashi Sofue (Japan)

 

Symposium: Pediatric Nephrology & CVD

(Joint with the Japanese Society for Pediatric Nephrology)

Chairs: Chih-Kang Chiang (Taiwan), Motoshi Hattori (Japan)

 

Clinical and genetic approaches and developing a novel treatment for Alport syndrome

Speaker: Kandai Nozu (Japan)

 

Pathogenic mechanism of childhood idiopathic nephrotic syndrome

Speaker: Yutaka Harita (Japan)

 

Bone - vascular link in paediatric CKD patients

Speaker: Rukshana Shroff (UK)

 

Cardiovascular risk factors in children with kidney diseases

Speaker: Christine B. Sethna (USA)

 

17:30-18:20

Special Lecture

(Sponsored by Boehringer Ingelheim GmbH Co., Ltd.)

 

SGLT2 inhibitors and diabetic kidney disease: The nephrologist’s point of view

 

Speaker: Christoph Wanner (Germany)

Chair: Akira Nishiyama (Japan)